- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Mochida Pharmaceutical (4534)
Mochida Pharmaceutical stock price live, this page displays TYO 4534 stock exchange data. View the 4534 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Mochida Pharmaceutical real time stock price chart below.
What Is the Mochida Pharmaceutical Stock Price Today?
The Mochida Pharmaceutical stock price today is 3,235.0.
What Is the Stock Symbol for Mochida Pharmaceutical?
The stock symbol for Mochida Pharmaceutical is ""4534.""
What Stock Exchange Does Mochida Pharmaceutical Trade On?
Mochida Pharmaceutical is listed and trades on the Tokyo stock exchange.
Is Mochida Pharmaceutical a Good Stock to Buy?
Determining whether Mochida Pharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4534 quote. (ISIN: JP3922800002)
What Is the Mochida Pharmaceutical Stock Price Today?
The Mochida Pharmaceutical stock price today is 3,235.0.
What Is the Stock Symbol for Mochida Pharmaceutical?
The stock symbol for Mochida Pharmaceutical is ""4534.""
What Stock Exchange Does Mochida Pharmaceutical Trade On?
Mochida Pharmaceutical is listed and trades on the Tokyo stock exchange.
Is Mochida Pharmaceutical a Good Stock to Buy?
Determining whether Mochida Pharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4534 quote. (ISIN: JP3922800002)
Tokyo
Currency in JPY
3,235.0
+10.0(+0.31%)
Closed·
Fair Value
An estimate of a Mochida Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,190.0
3,245.0
52 wk Range
2,836.0
3,625.0
4534 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
4534 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Mochida Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,190.03,245.0
52 wk Range
2,836.03,625.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.47%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.47%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4534 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Mochida Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Mochida Pharmaceutical Company Profile
Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. It offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology, including Lialda, Omvoh, and Cortiment for the treatment of ulcerative colitis; Goofice and Movicol for the treatment of chronic constipation; Epadel for hyperlidemia and arteriosclerosis obliterans; Urece for gout and hyperuricemia; Treprost for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; Atelec, a calcium channel blocker; Dinagest, an agent for endometriosis, adenomyosis, and dysmenorrhea; Lexapro, an antidepressant; Tamcet, an analgesic for chronic pain; Beselna, a therapeutic agent for condyloma acuminatum and actinic keratosis; and Heparin Sodium MOCHIDA anticoagulant agents. The company also develops mesalazine for the treatment of ulcerative colitis; tocilizumab for the treatment of rheumatoid arthritis; dotinurad for the treatment of gout and hyperuricemia; dienogest formulation for dysmenorrhea; treprostinil for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and icosapent for hypertriglyceridemia. In addition, it develops medical devices, including dMD-001 that is used for the treatment of articular cartilage lesions; dMD-002, which is used for the treatment of cavernous nerve injury; and dMD-003 for post-operative adhesion. Further, the company engages in the development, production, distribution, sale, and marketing of skincare products. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.
Compare 4534 to Peers and Sector
Metrics to compare | 4534 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4534PeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.0x | 12.7x | −0.5x | |
PEG Ratio | 0.51 | 0.15 | 0.00 | |
Price/Book | 0.9x | 1.0x | 2.6x | |
Price / LTM Sales | 1.1x | 1.5x | 3.3x | |
Upside (Analyst Target) | - | 12.5% | 42.9% | |
Fair Value Upside | Unlock | 12.1% | 6.2% | Unlock |
Earnings
Latest Release
Aug 01, 2025
EPS / Forecast
53.43 / --
Revenue / Forecast
26.63B / --
FAQ
What Stock Exchange Does Mochida Pharmaceutical Trade On?
Mochida Pharmaceutical is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for Mochida Pharmaceutical?
The stock symbol for Mochida Pharmaceutical is "4534."
What Is the Mochida Pharmaceutical Market Cap?
As of today, Mochida Pharmaceutical market cap is 114.68B.
What Is Mochida Pharmaceutical's Earnings Per Share (TTM)?
The Mochida Pharmaceutical EPS (TTM) is 169.95.
When Is the Next Mochida Pharmaceutical Earnings Date?
Mochida Pharmaceutical will release its next earnings report on 30 Oct 2025.
From a Technical Analysis Perspective, Is 4534 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Mochida Pharmaceutical Stock Split?
Mochida Pharmaceutical has split 4 times.
How Many Employees Does Mochida Pharmaceutical Have?
Mochida Pharmaceutical has 1508 employees.
What is the current trading status of Mochida Pharmaceutical (4534)?
As of 12 Aug 2025, Mochida Pharmaceutical (4534) is trading at a price of 3,235.00, with a previous close of 3,225.00. The stock has fluctuated within a day range of 3,190.00 to 3,245.00, while its 52-week range spans from 2,836.00 to 3,625.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.